ArticleActa pharmaceutica Sinica. B2025

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery.

Siqi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.